Tvardi Therapeutics, Inc. Financial Flexibility Index
Tvardi Therapeutics, Inc. financial flexibility index. Tvardi Therapeutics, Inc. (TVRD) has a Financial Flexibility Index of -1.01x as of June 2026. Free cash flow of $-9.23 Million (operating CF $-9.23 Million minus capex $0.00) represents -1% of total liabilities ($9.13 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tvardi Therapeutics, Inc. (2020–2025)
Financial flexibility index of Tvardi Therapeutics, Inc. from 2020 to 2025. Historical Financial Flexibility Index trend for Tvardi Therapeutics, Inc. across 6 annual periods. Check cash flow quality index of Tvardi Therapeutics, Inc. to evaluate the quality of earnings relative to operating cash generation.
Tvardi Therapeutics, Inc. Financial Flexibility Index by Year (2020–2025)
Tvardi Therapeutics, Inc. financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Tvardi Therapeutics, Inc.. For the full cash flow conversion analysis, see Tvardi Therapeutics, Inc. operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.11x | $-23.50 Million | $-23.50 Million | $11.13 Million | ▼ -70.8% |
| 2024 | -1.24x | $-59.87 Million | $-60.92 Million | $48.42 Million | ▼ -22.8% |
| 2023 | -1.01x | $-89.70 Million | $-92.08 Million | $89.06 Million | ▼ -409.7% |
| 2022 | -0.20x | $-17.82 Million | $-17.87 Million | $90.15 Million | ▲ +93.6% |
| 2021 | -3.07x | $-60.05 Million | $-60.09 Million | $19.53 Million | ▼ -1225.6% |
| 2020 | -0.23x | $-5.14 Million | $-5.49 Million | $22.16 Million | — |